You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antiretroviral interruption

Showing 1 - 25 of 2,374
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

Enrolling by invitation
  • HIV
  • Antiretroviral Therapy Interruption(ATI)
  • Washington, District of Columbia
  • +1 more
Sep 12, 2022

Post Analytic Treatment Interruption Study

Recruiting
  • HIV
    • Bangkok, Thailand
      SEARCH
    Oct 19, 2022

    Human Immunodeficiency Virus Trial in Boston, New York (3BNC117, 10-1074, Analytical treatment interruption)

    Completed
    • Human Immunodeficiency Virus
    • Boston, Massachusetts
    • +1 more
    Feb 11, 2022

    Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

    Not yet recruiting
    • Human Immuno-deficiency Virus (HIV) Disease
    • (no location specified)
    Sep 5, 2023

    HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

    Not yet recruiting
    • HIV Vaccine
    • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
    • +2 more
    • São Paulo, Brazil
      Hospital das Clínicas da Faculdade de Medicina da USP
    Mar 14, 2023

    HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Los Angeles, California
    • +11 more
    Jan 13, 2023

    HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Gaborone, Botswana
    • +10 more
    May 16, 2022

    HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

    Not yet recruiting
    • HIV-1-infection
    • Molepolole, Botswana
    • +8 more
    Sep 8, 2023

    HIV Trial in Bangkok (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Bangkok, Thailand
      SEARCH Thai Red Cross AIDS Research Centre Non-Network CRS
    Oct 29, 2021

    HIV Trial in France (Analytical Treatment Interruption (ATI))

    Not yet recruiting
    • HIV Infections
    • Analytical Treatment Interruption (ATI)
    • Aix-en-Provence, France
    • +29 more
    Jul 28, 2022

    Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

    Not yet recruiting
    • Chronic HIV Infection
    • 426c.Mod.Core-C4b
    • Adjuvant 3M-052-AF+Alum
    • Birmingham, Alabama
    • +6 more
    Aug 17, 2023

    Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

    Not yet recruiting
    • Human Immunodeficiency Virus
    • New York, New York
    • +2 more
    Jul 12, 2022

    HIV-1 Infection Trial in New York (3BNC117, ART Interruption)

    Completed
    Has Results
    • HIV-1 Infection
    • New York, New York
      The Rockefeller University
    Jul 8, 2020

    HIV Trial in American Samoa, Australia, United States (MRKAd5 HIV-1 gag/pol/nef, MRKAd5 HIV-1 gag/pol/nef )

    Completed
    • HIV Infections
    • MRKAd5 HIV-1 gag/pol/nef
    • MRKAd5 HIV-1 gag/pol/nef placebo
    • San Diego, California
    • +22 more
    Oct 28, 2021

    HIV Trial in United States (Aldesleukin)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 28, 2021

    Interruption and Re-Initiation of Antiretroviral Therapy on

    Completed
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 16, 2020

      HIV/AIDS Trial in San Francisco (Treatment Interruption Arm)

      Recruiting
      • HIV/AIDS
      • Treatment Interruption Arm
      • San Francisco, California
        University of California San Francisco
      Apr 27, 2022

      HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

      Recruiting
      • HIV-1-infection
      • Umlazi, South Africa
        FRESH Clinical Research Site: Females Rising through Education,
      Jan 4, 2023

      HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

      Withdrawn
      • HIV Infection
      • Analytical Treatment Interruption + bNAbs infusion
      • Milan, Lombardy, Italy
      • +3 more
      Aug 2, 2022

      HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

      Not yet recruiting
      • HIV-1-infection
      • ChAdOx1.tHIVconsv1
      • +7 more
      • San Diego, California
      • +11 more
      Oct 4, 2023

      HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)

      Recruiting
      • HIV
      • Acute Treatment Interruption
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 11, 2023

      HIV-patients Regarding Participation toHIV Cure-related Clinical

      Recruiting
      • HIV Seropositivity
      • Self-administered questionnaires
      • Semi-directive individual interviews
      • Lausanne, Switzerland
        CHUV
      Jul 22, 2022

      HIV/AIDS Trial in San Francisco (Combination Intervention)

      Active, not recruiting
      • HIV/AIDS
      • Combination Intervention
      • San Francisco, California
        Zuckerberg San Francisco General Hospital, University of Califor
      Mar 21, 2022

      HIV I Infection Trial in Melbourne (Nivolumab 10 MG/ML [Opdivo], Saline)

      Not yet recruiting
      • HIV I Infection
      • Nivolumab 10 MG/ML [Opdivo]
      • Saline
      • Melbourne, Victoria, Australia
        Alfred Hospital - Department of Infecious Diseases
      May 16, 2022

      Long-acting Injectable Cabotegravir + Rilpivirine

      Not yet recruiting
      • Patient Satisfaction
      • +3 more
        • Santiago, Region Metropolitana, Chile
          CICUC
        Apr 18, 2023